Naturecell

네이처셀 · 007390

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$1.4B (₩2T)

Overview

Company summary coming soon.

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$15M
▼ −35.9% YoY
Operating profit · FY2025
−US$2.6M
Turned to loss
Net income · FY2025
−US$2.1M
Turned to loss

Revenue

  • FY2023US$14M
  • FY2024US$23.4M
  • FY2025US$15M

Operating profit

  • FY2023−US$7.4M
  • FY2024US$433K
  • FY2025−US$2.6M

Net income

  • FY2023−US$8.5M
  • FY2024US$888.5K
  • FY2025−US$2.1M

Key ratios (FY2025)

ROE
-4.5%
Debt/Eq
18.6%
Op. margin
-17.6%
Net margin
-13.7%
Rev. YoY
▼ −35.9%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.